IDIBAPS organizes a new session of Toolbox, IDIBAPS Talks Series, a series of talks that addresses issues of general interest to the research community.
On Wednesday, April 20, 2022, at 15h, will take place the session 'How to build value through public and private partnerships in a big pharma company' that will feature Edgardo Ferrán, consultant in translational sciences. After the session, IDIBAPS researchers, regardless of their career level, will have the opportunity to meet with the expert.
The speaker will share his personal experience of more than twenty years acquired in the framework of a large pharmaceutical company. He will explain the research and development that is carried out in this type of company and will give examples of how to work in this field, in particular, he will focus on how to build value through public-private collaborations. He will then present the EMBL-EBI Industry Programme (a program of the European Bioinformatics Institute linked to the European Molecular Biology Laboratory). Furthermore, he will also emphasize the importance of networking between researchers and industry.
Edgardo Ferrán is a recognized expert in the pharmaceutical industry. He has worked twenty-four years at Sanofi after fourteen years in academia in Argentina. He is currently an external consultant to the EBI and the Center for Genomic Regulation, CRG; institutions with which he had previously collaborated scientifically. Likewise, he is also Board Director of the Catalan biotech company Pulmobiotics.
This activity is open to people from inside and outside the institution. It is a hybrid event, it will be possible to participate directly in the Esteve Auditorium of the Esther Koplowitz Center or via Zoom. To access digitally it is necessary to register in advance to receive a personal connection link, there is time until the same day to do so.
The activity is promoted by the Human Resources Strategy for Researchers (HRS4R) of the institution. This activity is part of the Fundació Clínic for Biomedical Research reference ECT2020-000811 funded by MCIN/AEI/10.13039/501100011033/ and by the European Union "NextGenerationEU"/PRTR.